Neovacs S.A. (ALNEV) — Financial Flexibility Index
Neovacs S.A. (ALNEV) has a Financial Flexibility Index of -0.63x as of December 2025. Free cash flow of €-2.60 Million (operating CF €-2.60 Million minus capex €1.18K) represents -1% of total liabilities (€4.10 Million). Check ALNEV strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Neovacs S.A. Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Neovacs S.A. across 19 annual periods. See Neovacs S.A. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Neovacs S.A. (2007–2025)
Year-by-year free cash flow to debt coverage for Neovacs S.A.. For the full company profile including market capitalisation, see ALNEV stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.23x | €-5.03 Million | €-5.03 Million | €4.10 Million | ▼ -39.5% |
| 2024 | -0.88x | €-3.52 Million | €-3.60 Million | €4.01 Million | ▼ -90.7% |
| 2023 | -0.46x | €-1.71 Million | €-1.91 Million | €3.71 Million | ▲ +45.8% |
| 2022 | -0.85x | €-4.30 Million | €-4.45 Million | €5.05 Million | ▲ +58.6% |
| 2021 | -2.05x | €-9.56 Million | €-9.91 Million | €4.65 Million | ▲ +5.4% |
| 2020 | -2.17x | €-5.44 Million | €-5.65 Million | €2.50 Million | ▼ -28.8% |
| 2019 | -1.69x | €-8.10 Million | €-8.10 Million | €4.80 Million | ▲ +39.1% |
| 2018 | -2.77x | €-13.30 Million | €-13.31 Million | €4.80 Million | ▼ -112.1% |
| 2017 | -1.31x | €-14.13 Million | €-14.26 Million | €10.82 Million | ▲ +3.1% |
| 2016 | -1.35x | €-10.88 Million | €-11.00 Million | €8.08 Million | ▲ +9.0% |
| 2015 | -1.48x | €-7.67 Million | €-7.69 Million | €5.18 Million | ▲ +35.7% |
| 2014 | -2.30x | €-8.03 Million | €-8.05 Million | €3.49 Million | ▼ -38.4% |
| 2013 | -1.66x | €-6.97 Million | €-7.00 Million | €4.19 Million | ▲ +31.9% |
| 2012 | -2.44x | €-6.33 Million | €-6.33 Million | €2.59 Million | ▲ +31.1% |
| 2011 | -3.55x | €-8.56 Million | €-8.63 Million | €2.41 Million | ▼ -6.4% |
| 2010 | -3.33x | €-8.01 Million | €-8.10 Million | €2.40 Million | ▼ -105.2% |
| 2009 | -1.62x | €-7.92 Million | €-7.95 Million | €4.88 Million | ▲ +20.2% |
| 2008 | -2.04x | €-4.46 Million | €-4.49 Million | €2.19 Million | ▲ +3.5% |
| 2007 | -2.11x | €-4.29 Million | €-4.32 Million | €2.04 Million | — |